Historical record - last NADAC publication: 4/17/2024
Product Information
DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Accord Healthcare Inc., priced at $0.3158 per EA under NDC 16729049112. Its NADAC has been published 193 times since Sep 9, 2020.
The High Outlier badge above means this manufacturer's average price in the Dofetilide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.25 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729049112
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213338On Market Since
8/20/2020
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 193 times since Sep 9, 2020, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3158 per EA |
|---|---|
| All-time high | $1.6904 (Sep 16, 2020) |
| All-time low | $0.3158 (Apr 17, 2024) |
| Median price | $0.8056 |
| Average price | $0.8913 |
| Largest weekly change | +51.6% (Aug 17, 2022) |
| Weeks tracked | 193 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Accord Healthcare Inc., is $0.3158 per EA (NDC 16729049112), effective May 15, 2024.
How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 81.3%. It has been tracked across 193 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?
Since Sep 9, 2020, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.3158 (Apr 17, 2024) to a high of $1.6904 (Sep 16, 2020), with a median of $0.8056 per EA.
Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DOFETILIDE 250 MCG CAPSULE, is $0.1886 per EA — about 40% below DOFETILIDE 250 MCG CAPSULE.
Who manufactures DOFETILIDE 250 MCG CAPSULE?
DOFETILIDE 250 MCG CAPSULE (NDC 16729049112) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification